Physician

Laura Ann Kalayjian, M.D.

According to 2025 Medicare claims, Laura Kalayjian, M.D. (NPI: 1205877917) practices epileptologists in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is USC CARE MEDICAL GROUP, INC (NPI: 1902846306; TIN: 954540991) and primary practice location at 90033-5313. Kalayjian is affiliated with the Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Kalayjian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 158 traditional Medicare patients, billed 390 HCPCS/CPT codes, and received $27,005 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,874 prescription claims across 118 beneficiaries totaling $1,070,789 in drug costs, led by Lamictal Xr (Lamotrigine). Open Payments data shows 4 records totaling $108. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $42,863 to $27,005. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $428,485 to $1,070,789. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.